Question 1

Who is Stanley Cohen and how did his discovery change biology?

Accepted Answer

Stanley Cohen, an American biochemist (1922-2020), discovered growth factors together with Rita Levi-Montalcini, notably epidermal growth factor (EGF). The key thing to remember is that these proteins are chemical signals that tell cells to divide or develop. Before Cohen, no one knew that specific molecules could orchestrate cell growth. His work paved the way for understanding cell signaling and, later, for cancer therapies targeting EGF receptors. He received the Nobel Prize in Physiology or Medicine in 1986 for these discoveries.

Question 2

Why is the discovery of nerve growth factor (NGF) considered a major breakthrough?

Accepted Answer

What makes NGF so decisive is that it demonstrated for the first time that chemical signals coming from outside nerve cells could control their growth and survival. Imagine that neurons were seen as cells programmed in an almost fixed way; Cohen and Levi-Montalcini showed that a simple protein could make nerve fibers grow within a ganglion. Discovered in 1954, NGF revolutionized neurobiology and proved the existence of a new class of molecules: growth factors. This work earned its two discoverers the 1986 Nobel Prize.

Question 3

How did Stanley Cohen isolate epidermal growth factor (EGF), and why did he use mouse salivary glands?

Accepted Answer

To understand this, you have to remember that Cohen was looking for an abundant source of the protein. He had noticed that injecting extracts from the submaxillary glands of male mice sped up eye opening and tooth eruption in newborn mice. What is striking here is the ingenuity: he used salivary glands, an unexpected tissue, because they contained a high concentration of EGF. In 1962, he purified this protein and showed its role in the development of epithelial cells. This discovery laid the foundations for understanding cell signaling.

Question 4

What is the connection between growth factors and cancer research?

Accepted Answer

What is often forgotten is that growth factors like EGF are not only important for normal development: abnormally active receptors, such as EGFR, can drive cells to divide uncontrollably, contributing to cancer. Cohen's work on EGF and its receptor made it possible to understand that blocking these signals could slow tumor growth. Today, drugs such as cetuximab or gefitinib target EGFR in certain lung or colon cancers. Less a piece of fundamental research than a direct bridge to personalized medicine.

Question 5

What did a typical day in Stanley Cohen's laboratory look like?

Accepted Answer

Picture Cohen, a quiet and passionate researcher, arriving early in the morning at Vanderbilt University. He spent his mornings at the bench, handling pipettes and centrifuges to purify proteins. In the afternoons, he analyzed his results and talked with his students, recording every observation in his lab notebook. What set him apart was that he preferred to work with his own hands rather than simply direct others. In the evening, he went home to Nashville and played the clarinet or the recorder, leading a simple life far from social affairs.

Question 6

Which objects in Cohen's laboratory were essential to his discoveries?

Accepted Answer

To understand how Cohen isolated EGF, you have to remember the tools of the 1960s biochemist. The pipette for measuring out precise volumes, the centrifuge for separating proteins from other components, and the spectrophotometer for measuring their concentration were his daily instruments. The microscope allowed him to observe the effect of growth factors on cells. But the most surprising object remains the mouse salivary glands, his unexpected biological source. These tools, now commonplace, were then at the cutting edge of biochemistry.

Question 7

What does the term 'growth factor' mean, and why is it essential in biology?

Accepted Answer

A growth factor is a protein that acts as a chemical signal: it binds to a cell receptor and triggers a cascade of reactions that prompt the cell to divide, develop, or survive. The key thing to remember is that without these molecules, cells would not know when to grow or repair themselves. Cohen's discoveries about EGF and NGF showed that these signals are specific: each type of cell responds to its own factor. This vocabulary is now at the heart of cell signaling and of our understanding of cancer.

Question 8

Why has the collaboration between Stanley Cohen and Rita Levi-Montalcini remained famous?

Accepted Answer

What is striking about this collaboration is how unlikely it was: Rita Levi-Montalcini, an Italian neurobiologist, and Stanley Cohen, an American biochemist, met at Washington University in St. Louis in 1953. Levi-Montalcini said that Cohen had “golden hands” for purifying proteins. Together, they discovered NGF in 1954, then EGF a few years later. Their partnership showed how biology and biochemistry could join forces to solve fundamental questions. They shared the Nobel Prize in 1986, more than thirty years after their first discoveries.

Question 9

What world events marked the period of Stanley Cohen's discoveries?

Accepted Answer

To understand the context, you have to remember that the 1950s and 1960s were the golden age of molecular biology. In 1953, Watson and Crick worked out the structure of DNA, transforming biology. It was also the era when the United States invested heavily in research after World War II. Cohen and Levi-Montalcini worked in this climate of scientific excitement. Later, in the 1970s and 1980s, their discoveries about growth factor receptors became part of the rise of cell signaling, a field that would lead to targeted cancer therapies in the 2000s.

Question 10

What are the key places in Stanley Cohen's life and career?

Accepted Answer

Cohen was born in 1922 in Brooklyn, New York, into a family of immigrants. He earned his doctorate at the University of Michigan in 1948. The turning point of his career came at Washington University in St. Louis, where he joined Levi-Montalcini's laboratory in 1953. In 1959, he moved to Vanderbilt University in Nashville, where he spent the rest of his career and isolated EGF. It was there that he died in 2020 at the age of 97. These places, from Brooklyn to Nashville, mark the journey of a quiet researcher whose discoveries shone across the entire world.

Stanley Cohen(1922 — 2020)

Frequently asked questions

Key Facts

Works & Achievements

Anecdotes

Primary Sources

Key Places

Liens externes & ressources

Références

Rechercher

See also

Related Characters